| Current Price | $138.24 | Mkt Cap | $9.9B |
|---|---|---|---|
| Open | $136.88 | P/E Ratio | 0.00 |
| Prev. Close | $0.00 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $134.09 - $141.00 | Volume | 329,465 |
| 52-Wk Range | $16.54 - $202.73 | Avg. Daily Vol. | 2,863,194 |
| Current Price | $138.24 | Mkt Cap | $9.9B |
|---|---|---|---|
| Open | $136.88 | P/E Ratio | 0.00 |
| Prev. Close | $0.00 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $134.09 - $141.00 | Volume | 329,465 |
| 52-Wk Range | $16.54 - $202.73 | Avg. Daily Vol. | 2,863,194 |
The best Bull and Bear pitches based on recency and number of recommendations.
It's hard not to imagine gene-editing as the future of medicine. The company has about $600 million in cash and short-term investments on its balance sheet, and recently received funding from the Bill & Melinda Gates Foundation. That cash cushion is… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about NTLA.
Recs
TMFRetireFoolish
(26.36)
Submitted: 7/8/2021 1:22:52 AM :
Start Price:
$151.10
NASDAQ:NTLA Score:
-10.57
CRSPR in vivo success would position for many new therapies and industry leadership
Recs
TMFjbonefish
(67.28)
Submitted: 5/5/2021 5:06:08 PM :
Start Price:
$72.96
NASDAQ:NTLA Score:
+85.13
It's hard not to imagine gene-editing as the future of medicine. The company has about $600 million in cash and short-term investments on its balance sheet, and recently received funding from the Bill & Melinda Gates Foundation. That cash cushion is important. Even if the company eventually delivers a treatment or treatments that lead to commercial success, that won't happen for a least a few years. For investors, therefore, owning Intellia stock requires a leap of faith.
Recs
CBK
(56.79)
Submitted: 4/23/2021 8:55:49 AM :
Start Price:
$70.36
NASDAQ:NTLA Score:
+91.44
Finishing Walter Isaacson's The Code Breaker has made me believe that the next revolution that we are living in is the genomic revolution. Companies like Illumina, Editas, Crispr, Moderna, and Intellia are powering this revolution.
Find the members with the highest scoring picks in NTLA.
birdup (34.08) Score: +1,230.64
The Score Leader is the player with the highest score across all their picks in NTLA.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| birdup | 34.08 | 3/16/2020 |
|
5Y | $9.87 | +1,313.75% | +83.11% | +1,230.64 | 0 Comment | |
| Playa14 | < 20 | 10/17/2019 |
|
5Y | $11.40 | +1,124.01% | +47.68% | +1,076.33 | 0 Comment | |
| allforone | 95.66 | 3/12/2020 |
|
5Y | $11.22 | +1,144.20% | +71.65% | +1,072.55 | 0 Comment | |
| TraderEnvy | < 20 | 10/4/2019 |
|
5Y | $11.94 | +1,068.66% | +51.49% | +1,017.17 | 0 Comment | |
| clangmead | 55.67 | 12/28/2018 |
|
5Y | $12.51 | +1,015.41% | +77.49% | +937.92 | 0 Comment | |
| CMFMLove | 75.49 | 6/13/2017 |
|
5Y | $12.67 | +1,001.32% | +80.87% | +920.45 | 1 Comment | |
|
ldigout | 98.34 | 4/13/2020 |
|
5Y | $13.05 | +969.25% | +59.10% | +910.15 | 0 Comment |
| Kevinkress | 88.95 | 5/4/2020 |
|
5Y | $13.09 | +965.99% | +57.20% | +908.78 | 0 Comment | |
| ZabasJ | 83.75 | 4/21/2020 |
|
5Y | $13.33 | +946.77% | +60.78% | +885.99 | 0 Comment | |
| prankjt17530 | 65.12 | 2/13/2017 |
|
5Y | $13.02 | +971.72% | +90.14% | +881.58 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
